Goldman Sachs’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Sell
413,912
-142,013
-26% -$535K ﹤0.01% 3570
2025
Q1
$2.52M Sell
555,925
-330,742
-37% -$1.5M ﹤0.01% 3204
2024
Q4
$6.27M Buy
886,667
+263,749
+42% +$1.86M ﹤0.01% 2675
2024
Q3
$5.07M Sell
622,918
-265,256
-30% -$2.16M ﹤0.01% 2744
2024
Q2
$5.68M Sell
888,174
-388,641
-30% -$2.48M ﹤0.01% 2522
2024
Q1
$9.61M Buy
1,276,815
+56,188
+5% +$423K ﹤0.01% 2068
2023
Q4
$11.3M Buy
1,220,627
+335,823
+38% +$3.11M ﹤0.01% 1974
2023
Q3
$8.95M Sell
884,804
-368,164
-29% -$3.73M ﹤0.01% 2064
2023
Q2
$15.7M Sell
1,252,968
-304,383
-20% -$3.8M ﹤0.01% 1723
2023
Q1
$18.2M Buy
1,557,351
+119,395
+8% +$1.39M ﹤0.01% 1584
2022
Q4
$15.3M Sell
1,437,956
-437,328
-23% -$4.65M ﹤0.01% 1812
2022
Q3
$18.2M Buy
1,875,284
+447,890
+31% +$4.34M ﹤0.01% 1673
2022
Q2
$20.7M Buy
1,427,394
+1,160,763
+435% +$16.8M 0.01% 1584
2022
Q1
$6.97M Buy
266,631
+139,427
+110% +$3.64M ﹤0.01% 2532
2021
Q4
$5.04M Sell
127,204
-55,590
-30% -$2.2M ﹤0.01% 2796
2021
Q3
$9.14M Buy
182,794
+81,754
+81% +$4.09M ﹤0.01% 2348
2021
Q2
$5.61M Buy
101,040
+70,712
+233% +$3.93M ﹤0.01% 2696
2021
Q1
$1.42M Sell
30,328
-53,928
-64% -$2.52M ﹤0.01% 3664
2020
Q4
$3.67M Sell
84,256
-128,761
-60% -$5.61M ﹤0.01% 2665
2020
Q3
$7.8M Buy
213,017
+184,735
+653% +$6.76M ﹤0.01% 2107
2020
Q2
$825K Buy
28,282
+696
+3% +$20.3K ﹤0.01% 3336
2020
Q1
$721K Buy
+27,586
New +$721K ﹤0.01% 3285
2019
Q4
Sell
-7,883
Closed -$249K 4326
2019
Q3
$249K Buy
+7,883
New +$249K ﹤0.01% 3845